InvestorsHub Logo
Followers 145
Posts 27565
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 1008

Thursday, 08/10/2017 8:17:18 AM

Thursday, August 10, 2017 8:17:18 AM

Post# of 3881
Dror Ben-Asher, Chief Executive Officer of RedHill, said:

"RedHill has transitioned into a revenue-generating, gastrointestinal-focused, specialty pharmaceutical company, as we continue to pursue important clinical development milestones in the near future. I would like to thank the RedHill team for their meaningful achievements on the R&D and commercial fronts thus far in 2017."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News